• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM 1.43% 35.5¢

IMMUTEP LIMITED

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMM
Overnight Market report
43 44 45
06:27 2.6K 1.0M
06:27 Last post  ahjay Comments Created with Sketch.  2.6K  Views Created with Sketch.  1.0M 
IMM 19/04/24 11 4.3K
19/04/24 Last post  guidorampaz Comments Created with Sketch.  11  Views Created with Sketch.  4.3K 
IMM
Media
11 12 13
19/04/24 734 319K
TRENDING NEWS

Crypto world awaits overnight Bitcoin halving event

NEWS
19 Apr 2024
19/04/24 Last post  ahjay Comments Created with Sketch.  734  Views Created with Sketch.  319K 
IMM 19/04/24 10 3.5K
19/04/24 Last post  Bylosellhi Comments Created with Sketch.  10  Views Created with Sketch.  3.5K 
IMM
Marc do your job!
18/04/24 11 3.5K
18/04/24 Last post  coolkiat Comments Created with Sketch.  11  Views Created with Sketch.  3.5K 
IMM 17/04/24 4 1.9K
17/04/24 Last post  SouthernAccent Comments Created with Sketch.  4  Views Created with Sketch.  1.9K 
IMM 15/03/24 56 28K
15/03/24 Last post  Bylosellhi Comments Created with Sketch.  56  Views Created with Sketch.  28K 
IMM 08/03/24 2 1.6K
08/03/24 Last post  ahjay Comments Created with Sketch.  2  Views Created with Sketch.  1.6K 

See All Discussions arrow Created with Sketch.

Timeline

CHDR to conduct first-in-human phase 1 trial of IMP761
18 Apr 09:36
 
Positive Feedback received from Spanish Medicines Agency
17 Apr 09:10
 
Ceasing to be a substantial holder
11 Apr 18:30
 
Ceasing to be a substantial holder
08 Mar 16:27
 
First Clinical Data announced from 90mg Dosing of Efti
05 Mar 12:34
 
Half Yearly Report and Accounts
28 Feb 09:39
 
View More arrow Created with Sketch.
(20min delay)
Last
35.5¢
Change
0.005(1.43%)
Mkt cap ! $422.0M
Open High Low Value Volume
35.0¢ 35.5¢ 34.3¢ $421.7K 1.202M

Buyers (Bids)

No. Vol. Price($)
2 4350 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 62505 2
View Market Depth
Last trade - 16.10pm 19/04/2024 (20 minute delay) ?
Last
35.5¢
  Change
0.005 ( 0.65 %)
Open High Low Volume
35.5¢ 35.5¢ 34.5¢ 197020
Last updated 15.59pm 19/04/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.